Ureteroscopy — the direct endoscopic visualisation of the ureter and renal collecting system using rigid, semi-rigid, or flexible ureteroscopes introduced through the urethra and bladder into the ureteral orifice, advanced over a safety guidewire under fluoroscopic guidance and direct vision to the target lesion in the ureter or kidney; enabling the diagnostic and therapeutic scope of procedures that includes holmium:YAG laser lithotripsy for ureteral and renal calculi using high-power high-frequency pulse modulation with dusting techniques that reduce stone fragments to sub-millimetre particles requiring no basket retrieval or fragmentation techniques producing fragments collected with nitinol basket extractors; biopsy and fulguration of upper tract urothelial carcinoma of the ureter and renal pelvis for diagnostic staging and selective ablative treatment; direct visualisation and endoscopic incision of ureteral strictures at the ureteropelvic junction or ureteroureteric anastomosis following urinary diversion; surveillance of known upper tract urothelial carcinoma following conservative kidney-sparing management in patients with bilateral disease, solitary kidney, or chronic kidney disease precluding nephroureterectomy; and retrograde intrarenal surgery using deflectable flexible ureteroscopes with tip deflection above two hundred and seventy degrees enabling access to all renal calyces including the lower pole; facilitated by the digital high-definition ureteroscope systems providing superior image resolution over fibre-optic predecessors, single-use disposable ureteroscope platforms eliminating instrument sterilisation cycles and reducing the cost of repair-associated downtime, ureteral access sheath technology reducing intrarenal pressure during irrigation while improving visualisation and instrument passage, and suction lithotripsy systems evacuating stone dust and fluid during laser lithotripsy — requiring a technology infrastructure spanning endoscopy platform software coordinating the procedure list, equipment checklist, and operative records; surgical planning platforms managing the pre-operative computed tomography review, stone burden estimation, and anaesthetic assessment; intra-operative documentation platforms recording the laser energy settings, stone-free assessment, stent placement decisions, and basket retrieval strategy; and post-operative platforms managing stent removal scheduling, stone-free rate imaging, and recurrence prevention.
Ureteroscopy technology platforms — whether supporting pre-operative assessment platforms coordinating the computed tomography stone characterisation review, renal function assessment, coagulation screening, ureteral access assessment, and anaesthetic risk stratification that enable the elective ureteroscopy list to proceed safely; intra-operative documentation platforms recording the access sheath calibre and length, flexible or rigid ureteroscope model, holmium or thulium laser energy settings and pulse duration, stone-free assessment by fluoroscopy or direct visualisation, basket extraction details and fragment weight, ureteral stent placement with size and planned removal date, and operative complication documentation; post-operative management platforms managing the stent symptom assessment, stent removal cystoscopy scheduling, post-procedure imaging for stone-free rate confirmation, and metabolic stone evaluation referral; single-use endoscope tracking platforms managing the device inventory, scope activation code registration, and usage analytics for the single-use ureteroscope systems that have transformed equipment management in high-volume stone units; and endoscopy reporting platforms integrating the ureteroscope video capture with the operative report to provide the image-annotated documentation that supports medicolegal records, morbidity and mortality review, and ureteral injury tracking — must maintain the availability and performance standards that pre-operative planning, intra-operative documentation, post-operative stent management, and stone-free surveillance demand. This guide explains why ureteroscopy tech platforms need dedicated monitoring, what components to monitor, and how to build a monitoring strategy that matches the pre-operative, intra-operative, post-operative, and single-use device management demands of modern ureteroscopy care.
Why Ureteroscopy Tech Platforms Require Specialized Monitoring Attention
Ureteroscopy management is defined by three platform-dependent priorities that reflect the clinical obligation to characterise the target stone or lesion before the procedure determines the operative approach, document the intra-operative laser parameters and stent placement decisions that determine post-operative management, and coordinate the stent removal and stone-free rate imaging that closes the procedural episode: the requirement for pre-operative imaging platforms that characterise stone burden and ureteral access to determine the operative strategy; the intra-operative documentation platforms recording laser parameters, access details, and stent placement decisions that guide post-operative management; and the post-operative coordination platforms managing stent removal scheduling, stone-free rate imaging, and upper tract surveillance in oncology cases.
Pre-operative imaging and assessment platforms characterise the target lesion and ureteral access. Diagnostic imaging and surgical planning platforms delivering the computed tomography and retrograde pyelography that determine the ureteroscopy operative approach — where the computed tomography stone burden measurement estimates the retrograde intrarenal surgery operative duration and predicts the stone-free rate achievable in a single procedure for the given stone volume and lower pole anatomy; where the stone density in Hounsfield units predicts holmium laser lithotripsy fragmentation efficiency and determines whether high-power fragmentation or low-power dusting settings are the preferred lithotripsy strategy; where the skin-to-stone distance and body habitus assessment informs the expected endoscope torque and the access sheath size selection; where the ureteral diameter on computed tomography and the history of prior ureteral surgery, percutaneous nephrolithotomy, or extracorporeal shock wave lithotripsy informs the risk of ureteral access failure requiring passive ureteral dilation with a stent over two to four weeks before reattempting ureteroscopy; where the retrograde pyelogram performed at the start of the ureteroscopy under fluoroscopy characterises the ureteral anatomy, identifies the stricture or tortuosity requiring guidewire manipulation, and defines the calyceal anatomy guiding the flexible ureteroscope deflection to the target calyx — are the planning foundation; failures during the pre-operative computed tomography review for a fifty-two-year-old man with a sixteen-millimetre lower pole renal calculus and a previous failed extracorporeal shock wave lithotripsy — where the urologist is accessing the stone density of nine hundred and forty Hounsfield units confirming the hard calcium oxalate monohydrate composition that predicts poor shock wave fragmentation and excellent holmium laser lithotripsy efficiency, the lower pole infundibulopelvic angle of thirty-two degrees confirming the challenging lower pole access requiring tip deflection beyond two hundred and fifty degrees, and the prior ureteroscopy records showing a six French ureteral access sheath was achievable in the previous procedure — prevent the operative planning that determines the laser power settings, access sheath selection, and single-use ureteroscope model for the planned retrograde intrarenal surgery. Monitor imaging platforms at 1-minute intervals during active pre-operative ureteroscopy planning sessions.
Intra-operative documentation platforms record laser parameters and stent placement decisions. Operative documentation platforms capturing the intra-operative ureteroscopy records — where the ureteral access sheath size and length, the flexible ureteroscope model and deflection angle achieved, the safety guidewire and working guidewire types employed, and the initial retrograde pyelogram findings documenting the ureteral calibre and calyceal anatomy are recorded at procedure commencement; where the holmium laser power settings in watts, pulse energy in joules, frequency in hertz, and total energy delivered in kilojoules are documented for each stone fragment or lesion treated; where the dusting versus fragmentation strategy selection and the basket extraction details including number and size of retrieved fragments are recorded; where the intra-operative fluoroscopic stone-free assessment result — complete clearance, clinically insignificant residual fragments below four millimetres, or residual stone burden requiring a second procedure — is documented; where the ureteral injury characterisation including ureteral wall perforation, mucosal avulsion, or avulsion requiring immediate open or laparoscopic repair is recorded if a complication occurs; where the double-J ureteral stent size and planned removal date are recorded in the operative notes; and where the post-operative haematuria assessment and anaesthetic recovery documentation complete the operative record — are the intra-operative documentation infrastructure; failures during the operative record completion following a sixty-seven-year-old woman's ureteroscopy for a transitional cell carcinoma biopsy and fulguration in the left renal pelvis — where the scrub nurse is documenting the biopsy site, the fulguration power settings, and the planned surveillance ureteroscopy interval in the operative record that will inform the oncology team's upper tract surveillance plan — prevent the operative documentation that the multidisciplinary team requires to plan the post-procedural oncological management. Monitor operative documentation platforms at 1-minute intervals during active ureteroscopy list sessions.
Post-operative coordination platforms manage stent removal and stone-free surveillance. Post-operative management platforms coordinating the clinical episode following ureteroscopy — where the ureteral stent removal scheduling with cystoscopy booking at the planned four-to-six-week interval prevents the stent encrustation and migration complications of retained stents; where the post-procedure imaging for stone-free rate assessment at three months by ultrasound or low-dose computed tomography provides the outcome documentation; where the stent symptom assessment by post-operative telephone review at one week characterises the degree of lower urinary tract storage symptoms, haematuria, and loin discomfort attributable to the indwelling double-J stent; where the oncological upper tract surveillance scheduling following ureteroscopic biopsy and fulguration of upper tract urothelial carcinoma coordinates the three-monthly surveillance ureteroscopy intervals with the urine cytology and upper tract imaging schedule; and where the metabolic stone evaluation referral for recurrent stone formers initiates the twenty-four-hour urine biochemistry protocol that identifies the treatable stone risk factors — are the post-procedural coordination infrastructure; failures during the stent tracking review for a forty-one-year-old man whose double-J stent following right ureteroscopy was placed seven weeks ago and is now two weeks beyond the planned removal date — where the urology coordinator is accessing the stent placement record to confirm the stent size and urgently book the overdue stent removal cystoscopy — prevent the stent management coordination that avoids the encrustation complications disproportionately affecting patients with forgotten or overdue ureteral stents. Monitor post-operative coordination platforms at 1-minute intervals during active stent tracking and surveillance scheduling sessions.
What to Monitor on a Ureteroscopy Tech Platform
Pre-operative Assessment Platforms
Monitor pre-operative records for ureteroscopy planning (computed tomography stone size, density, and location characterisation; ureteral access assessment including prior ureteroscopy records and stent insertion notes; renal function and electrolyte results for anaesthetic risk and contrast use; coagulation screen for anticoagulant management; ureteral stenting for passive dilation requirement documentation; anaesthetic assessment records; and consent documentation covering ureteral injury, haematuria, stent requirement, and stone-free rate probability), and pre-operative platforms at 1-minute intervals during active planning sessions. Alert immediately — pre-operative platform failures during the planning review for a forty-eight-year-old man with a fourteen-millimetre calculus and a single kidney on anticoagulation — where the urologist is accessing the computed tomography stone density, the haematology anticoagulant bridging protocol, and the anaesthetic high-risk assessment to confirm the procedure is safe to proceed — prevent the multi-parameter safety confirmation required before this high-risk procedure.
Intra-operative Documentation Platforms
Monitor intra-operative records for ureteroscopy procedure documentation (ureteral access sheath size and length; flexible or rigid ureteroscope model; laser energy settings and total energy delivery; stone-free assessment by fluoroscopy; biopsy site and fulguration documentation for oncological cases; ureteral injury characterisation and immediate management; double-J stent size, manufacturer, batch number, and planned removal date; and post-operative haematuria assessment), and intra-operative documentation platforms at 1-minute intervals during active ureteroscopy list sessions. Alert immediately — intra-operative platform failures when a theatre nurse is documenting the operative details for a complex retrograde intrarenal surgery for a three-centimetre renal pelvis calculus — where the laser energy delivery of forty-two kilojoules, the three-pass flexible ureteroscopy access, the residual four-millimetre lower pole fragment, and the double-J stent placement are the operative parameters that the clinical governance team and the post-operative management team require.
Single-Use Ureteroscope Tracking Platforms
Monitor single-use device records for ureteroscope inventory and usage tracking (device inventory levels by ureteroscope model and size; activation code registration confirming device authentication; per-procedure device assignment and batch traceability; reorder threshold alerts; expiry date monitoring for device sterility; and usage analytics for cost-per-procedure tracking and procurement planning), and device tracking platforms during clinic hours. Alert on sustained failures — single-use ureteroscope tracking platform outages prevent the theatre coordinator from confirming the available inventory of single-use flexible ureteroscopes before a five-case stone list, risking list cancellation when a device is unavailable for the fourth or fifth case.
Endoscopy Reporting Platforms
Monitor endoscopy reporting records for ureteroscopy procedure documentation (video capture integration with operative report; image annotation of biopsy sites, stone fragments, and ureteral findings; report generation and distribution to referring urology team and oncology multidisciplinary team; and prior ureteroscopy report access for surveillance comparison in oncological upper tract cases), and endoscopy reporting platforms at 1-minute intervals during active ureteroscopy list sessions. Alert immediately — endoscopy reporting platform failures during the upper tract urothelial carcinoma surveillance ureteroscopy for a sixty-three-year-old woman with a known right renal pelvis tumour — where the urologist needs to annotate the surveillance images for comparison with the previous surveillance ureteroscopy six months ago and distribute the annotated report to the oncology multidisciplinary team — prevent the surveillance documentation that determines the next interval and oncological management.
Post-operative Management Platforms
Monitor post-operative records for stent and surveillance coordination (double-J stent removal cystoscopy scheduling and confirmation; stone-free rate imaging referral at three months; post-operative telephone review at one week for stent symptom assessment; upper tract surveillance ureteroscopy scheduling for oncological cases; metabolic stone evaluation referral for recurrent stone formers; and stent overdue alerts triggering urgent stent removal booking when the planned removal date has passed), and post-operative management platforms at 1-minute intervals during active coordination sessions. Alert immediately — post-operative platform failures when a urology nurse is reviewing the stent registry to identify all patients with double-J stents placed more than six weeks ago who have not yet had removal confirmed, to prevent the encrustation and upper tract damage of forgotten stents.
Patient Communication Platforms
Monitor patient portal records for ureteroscopy follow-up (stent symptom guidance for expected dysuria, frequency, haematuria, and loin discomfort versus the fever and rigors requiring emergency attendance; stent removal appointment confirmation; post-procedure imaging appointment booking; fluid intake targets for stone prevention; dietary guidance for stone type; and upper tract surveillance appointment scheduling for oncological cases), and patient communication platforms during business and evening hours. Alert on sustained failures — patient portal outages prevent a thirty-six-year-old woman with an indwelling double-J stent from accessing the guidance on the fever and loin pain that should prompt her to attend the emergency department and from confirming her stent removal cystoscopy appointment.
Authentication and Clinical Identity
Monitor authentication at 1-minute intervals, 24/7. Ureteroscopy programs coordinate across pre-operative assessment platforms, intra-operative documentation systems, single-use device tracking platforms, endoscopy reporting systems, post-operative management platforms, and patient communication portals — authentication failures block pre-operative computed tomography access during operative planning, operative record completion during active theatre lists, and stent registry access during overdue stent identification reviews.
SSL Certificates
Monitor SSL certificate expiry across all pre-operative, intra-operative, device tracking, endoscopy reporting, post-operative, and patient communication platforms. Certificate errors disrupt pre-operative imaging access during theatre planning and patient portal access during post-procedure stent symptom guidance.
HIPAA and Data Privacy Considerations
Ureteroscopy technology platforms handle PHI including pre-operative records with computed tomography stone characteristics and anticoagulant bridging protocols, intra-operative records with laser energy delivery details and operative complication documentation, single-use device records with procedure-to-device traceability, endoscopy reporting records with annotated ureteroscopy video and biopsy site images, post-operative records with stent management details, and patient portal records containing post-procedure symptom guidance and surveillance scheduling.
The particular sensitivity of ureteroscopy PHI includes the oncological implications — where upper tract urothelial carcinoma biopsied during diagnostic ureteroscopy represents a cancer diagnosis with insurance and employment implications; where surveillance ureteroscopy records documenting recurrence or progression of upper tract urothelial carcinoma in a patient managed conservatively with ablation rather than nephroureterectomy reflects an active oncological management decision; and where intra-operative complication documentation including ureteral perforation and avulsion represents medicolegally sensitive operative quality information — requiring careful access controls within clinical platforms. Technology platforms managing ureteroscopy PHI must implement HIPAA Security Rule requirements for availability and integrity. Availability monitoring provides operational documentation relevant to HIPAA Security Rule compliance for pre-operative, intra-operative, device tracking, endoscopy reporting, post-operative, and patient communication programs managing ureteroscopy care.
Alerting Strategy for Ureteroscopy Tech Platforms
Immediate alerting during pre-operative planning sessions: Imaging and assessment platforms during computed tomography and prior record review — stone density, ureteral access history, and renal function determine laser strategy, access sheath selection, and procedure safety.
Immediate alerting during active ureteroscopy theatre lists: Intra-operative documentation and endoscopy reporting platforms during operative record completion — laser energy delivery, stent placement decisions, complication characterisation, and biopsy documentation are the medicolegal and clinical governance record.
Immediate alerting during stent registry review sessions: Post-operative management platforms during overdue stent identification reviews — stent encrustation begins to accelerate beyond six weeks and causes severe upper tract complications in forgotten stents.
Immediate alerting during oncological surveillance planning sessions: Endoscopy reporting and post-operative platforms during upper tract urothelial carcinoma surveillance scheduling — three-monthly surveillance interval confirmation and recurrence documentation determine the oncological management escalation decision.
Sustained-failure alert (10–15 minutes): Single-use device tracking platforms for inventory level monitoring outside active theatre sessions; pre-operative platforms for routine elective procedure scheduling.
Sustained-failure alert (15–30 minutes): Patient portal platforms for stent symptom guidance, post-procedure imaging scheduling, and dietary stone prevention advice.
30-day advance warning: SSL certificates across all domains.
Vigilmon's multi-region monitoring confirms ureteroscopy platform availability from the geographies where pre-operative assessment services, surgical theatres, single-use device tracking systems, endoscopy reporting platforms, post-operative management teams, and patient communication systems coordinate the stone fragmentation, oncological biopsy, stricture incision, and surveillance procedures that constitute modern ureteroscopy care.
Status Page for Ureteroscopy Care Team Communication
A real-time status page gives pre-operative assessment coordinators reviewing computed tomography stone burden before elective lists, theatre nurses managing single-use ureteroscope inventory for active stone lists, intra-operative documentation specialists completing operative records during ureteroscopy cases, endoscopy reporting physicians annotating upper tract urothelial carcinoma surveillance images, post-operative coordinators managing stent removal scheduling and overdue stent identification, and patient portal managers delivering post-procedure stent symptom guidance immediate platform visibility without requiring IT support contact. During an intra-operative documentation platform outage when a ureteroscopy theatre list is mid-way through a four-case stone programme — where the operative records for the completed cases including the laser energy delivery, stent placement details, and stone-free assessments cannot be accessed or the new cases cannot be initiated on the electronic operative record system — a status page enables immediate escalation to paper-based intra-operative documentation with planned transcription after restoration, confirming the list can continue safely without electronic operative record access and preventing unnecessary list cancellation.
Include the status page URL in pre-operative assessment downtime protocols, surgical theatre downtime procedures, endoscopy reporting downtime protocols, post-operative management downtime procedures, and patient communication downtime procedures.
Vigilmon Setup for Ureteroscopy Tech Platforms
A practical starting configuration:
| Monitor | Check Interval | Alert Channel | |---------|----------------|---------------| | Authentication | 1 min | Slack + PagerDuty (24/7) | | Pre-operative assessment / computed tomography and planning records | 1 min | Slack + PagerDuty (clinic hours) | | Intra-operative documentation / laser records and stent placement | 1 min | Slack + PagerDuty (theatre hours) | | Single-use device tracking / inventory and activation | 2 min | Slack (business hours) | | Endoscopy reporting / video capture and oncology documentation | 1 min | Slack + PagerDuty (theatre hours) | | Post-operative management / stent registry and surveillance scheduling | 1 min | Slack + PagerDuty (clinic hours) | | Patient portal / stent guidance and post-procedure follow-up | 2 min | Slack + PagerDuty (business + evening hours) | | SSL: all domains | Daily | Email (30-day warning) |
Getting started:
- Create a free account at vigilmon.online
- Add authentication endpoints at 1-minute intervals with 24/7 alerting
- Configure pre-operative assessment platforms with immediate alerting during computed tomography review sessions — stone density, ureteral access history, and anticoagulant management determine operative strategy and procedure safety
- Add intra-operative documentation platforms with immediate alerting during active theatre lists — laser energy delivery, stent placement, and complication characterisation are the operative medicolegal record
- Configure single-use ureteroscope tracking platforms with sustained-failure alerting — inventory outages discovered mid-list cause list cancellations and patient harm from delayed stone treatment
- Add endoscopy reporting platforms with immediate alerting during active ureteroscopy lists and oncological surveillance sessions — annotated video documentation and multidisciplinary team distribution are the oncological care record
- Configure post-operative management platforms with immediate alerting during stent registry review sessions — overdue stent identification prevents the upper tract damage of retained ureteral stents
- Add patient portal platforms with sustained-failure alerting for stent symptom guidance, post-procedure imaging scheduling, and stone dietary prevention advice
- Enable SSL certificate monitoring across all pre-operative, intra-operative, device tracking, endoscopy reporting, post-operative, and patient communication domains
- Add the status page URL to pre-operative assessment, surgical theatre, endoscopy reporting, post-operative management, and patient communication downtime protocols
Conclusion
Ureteroscopy technology platforms are embedded in clinical decisions where pre-operative imaging platform availability when a urologist is reviewing the computed tomography findings for a sixty-year-old man with a seventeen-millimetre left lower pole renal calculus who failed extracorporeal shock wave lithotripsy twelve weeks ago — where the stone density of eight hundred and eighty Hounsfield units confirming hard calcium oxalate monohydrate composition, the lower pole infundibulopelvic angle of thirty-five degrees confirming the challenging deflection requirements, and the prior ureteroscopy note showing that the ureteral orifice accepted a twelve-French access sheath without passive dilation are the three parameters that determine whether the planned retrograde intrarenal surgery proceeds with a high-power holmium dusting protocol, a fourteen-French access sheath, and a single-use flexible ureteroscope with two-hundred-and-seventy-degree deflection — cannot be interrupted by a PACS platform failure that prevents the computed tomography from loading at the moment the urologist is finalising the laser protocol for the following morning's theatre list; where intra-operative documentation platform availability when a theatre nurse is completing the operative record mid-procedure for a forty-four-year-old woman undergoing ureteroscopic biopsy and fulguration of a left renal pelvis urothelial carcinoma — where documenting the biopsy site using the endoscopic image annotation function, the fulguration power settings applied, the macroscopic tumour appearance of a three-millimetre sessile lesion with no evidence of visible invasion, and the planned three-month surveillance interval are the operative record entries that the oncology multidisciplinary team meeting the following Tuesday requires to determine whether the patient proceeds to nephroureterectomy or continues on the kidney-sparing surveillance programme — cannot be interrupted by an endoscopy reporting platform failure that prevents the intra-operative image annotation and report distribution that constitute the oncological care record; and where post-operative management platform availability when a urology coordinator is reviewing the stent registry to identify patients with double-J stents overdue for removal — where the registry shows a fifty-seven-year-old man's ureteral stent placed nine weeks ago following ureteroscopy for a fifteen-millimetre ureteral calculus has not had a removal cystoscopy booked, and the coordinator is urgently arranging an overdue stent removal within the next forty-eight hours to prevent the encrustation that begins to accelerate beyond eight weeks and can progress to the complete upper tract obstruction and renal impairment of a forgotten encrusted stent — cannot be interrupted by a post-operative platform failure that prevents the stent registry access that identifies and rescues the patient from the preventable complication of a retained and encrusting ureteral stent. A pre-operative imaging platform unavailable when the stone characteristics are determining the laser protocol, an intra-operative documentation platform inaccessible when the oncological biopsy findings are determining the surveillance plan, a post-operative management platform unavailable when the stent registry is identifying the overdue stent requiring urgent removal — these are not IT incidents. They are clinical disruptions in one of the highest-volume endoscopic procedures in urological practice, where the pre-operative stone characterisation that determines single-procedure stone-free probability, the intra-operative documentation that supports oncological multidisciplinary team decision-making, and the post-operative stent tracking that prevents the upper tract complications of retained devices make every technology supporting the pre-operative assessment service, surgical theatre, endoscopy reporting system, post-operative coordination team, device tracking platform, and patient communication system a direct determinant of whether patients undergoing ureteroscopy receive the stone-free-status-achieving, oncologically-documented, stent-complication-preventing care this foundational urological procedure demands.
Uptime monitoring gives ureteroscopy tech teams the detection capability to identify failures within seconds, trigger immediate clinical downtime procedures, and demonstrate to urological surgery departments, endoscopy reporting services, single-use device procurement teams, oncological multidisciplinary teams, post-operative coordination services, and compliance auditors that platform operational reliability matches the pre-operative stone characterisation demands, intra-operative documentation obligations, single-use device inventory requirements, endoscopic oncology reporting standards, post-operative stent management commitments, and stone-free rate surveillance obligations of modern ureteroscopy care.
Start monitoring your ureteroscopy care tech platform for free at vigilmon.online — HTTP/HTTPS monitoring, multi-region consensus alerting, SSL certificate monitoring, automatic status page, Slack and webhook alerts. No agent required. No credit card.
Tags: #monitoring #ureteroscopy #retrogradeintrarenaalsurgery #holmiumlaser #thuliumlaser #ureteralstonelithotripsy #uppertracturothelialcarcinoma #uretericsurgery #singleuseureteroscope #doubleJstent #ureteralstent #stentmanagement #HIPAA #healthtech #digitalhealth #uptime #sre